An immunochemical study on tau glycation in paired helical filaments

Brain Research

Volumn 830, Issue 2, 1999, Pages 301-313

  Ko, Li Wen ^a,b   Ko, Eric C ^c   Nacharaju, Parimala ^a,b   Liu, Wan Kyng ^a,b   Chang, Emmanuel ^c   Kenessey, Agnes ^a   Yen, Shu Hui C ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c NONE

Author keywords

Alzheimer's disease; Glycation; PHF; Tau

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; GLUCOSE; GLUCOSE 6 PHOSPHATE; LYSOZYME; RABBIT ANTISERUM; RIBONUCLEASE; RIBOSE; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; COVALENT BOND; CROSS LINKING; DIABETES MELLITUS; GLYCATION; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; IMMUNOREACTIVITY; NEUROFIBRILLARY TANGLE; OXIDATION; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; PROTEIN PROCESSING; SENILE PLAQUE; STRUCTURE ACTIVITY RELATION;

ADULT; ALZHEIMER DISEASE; ANTIBODIES; CASE-CONTROL STUDIES; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROFIBRILLARY TANGLES; TAU PROTEINS;

EID: 0033526623     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01415-8     Document Type: Article

References (74)

1. Arai K., Maguchi S., Fujii S., Ishsibashi H., Oikawa K., Tanigushi N. Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites. J. Biol. Chem. 262:1987;16969-16972.
2. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., Wiche G., Seitelberger F., Grundke-Iqbal I., Iqbal K., Wisniewski H.M. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477:1989;90-99.
3. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
4. J.W. Baynes, V.M. Monnier (Eds.), The Maillard reaction in aging, diabetes and nutrition, Prog. Clin. Biol. Res. Vol. 304, Alan R. Liss, New York, 1989.
5. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin. Diabetes. 32:1983;680-684.
6. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1988;1315-1321.
7. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46:1995;223-234.
8. Bucala R., Makita Z., Vega G., Grundy S., Koschinsky T., Cerami A., Vlassara H. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci. USA. 91:1994;9441-9445.
9. Bunn H.F., Gabbay K.H., Gallop P.M. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science. 200:1978;21-27.
10. Cerami A., Stevens V.J., Monnier V.M. Role of nonenzymatic glycosylation in the development of the sequelae of diabetes mellitus. Metabolism: Clin. Exp. 28:1979;431-437.
11. Cerami A. Hypothesis. Glucose as a mediator of aging. J. Am. Geriat. Soc. 33:1985;626-634.
12. Day J.F., Thorpe S.R., Baynes J.W. Nonenzymatically glycosylated albumin: in vitro preparation and isolations from normal human serum. J. Biol. Chem. 254:1979;595-597.
13. Fisher G.H., Payan I.L., Chou S.J., Man E.H., Cerwinski S., Martin T., Emory C., Frey W.H. II Racemized D-aspartate in Alzheimer neurofibrillary tangles. Brain Res. Bull. 28:1992;127-131.
14. Garner M.H., Wang G.M., Spector A. Stimulation of glucosylated lens epithelial Na, K-ATPase by an aldose reductase inhibitor. Exp. Eye. Res. 45:1987;339-345.
15. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:1989;519-526.
16. Goedert M., Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau protein in brain and effects on tubulin polymerization. EMBO J. 9:1990;4225-4230.
17. Greenberg S.G., Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA. 87:1990;5827-5831.
18. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA. 83:1986;4913-4917.
19. Iberg N., Fluckiger R. Nonenzymatic glycosylation of albumin in vivo: identification of multiple glycosylated sites. J. Biol. Chem. 261:1986;13542-13545.
20. Ihara Y., Nukina N., Miura R., Ogawara M. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J. Biochem. 99:1986;1807-1810.
21. Iqbal K., Grundke-Iqbal I., Zaidi T., Ali N., Wisniewski H.M. Are Alzheimer neurofibrillary tangles insoluble polymers? Life Sci. 38:1986;1695-1700.
22. Katzman R. Alzheimer's disease. N. Engl. J. Med. 314:1986;964-973.
23. Kenessey A., Yen S.-H, Liu W.-K., Yang X.R., Dunlop D.S. Detection of D-aspartate in tau proteins associated with Alzheimer paired helical filaments. Brain Res. 675:1995;183-189.
24. Kenessey A., Nacharaju P., Ko L., Yen S.-H. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J. Neurochem. 69:1997;2026-2038.
25. Kidd M. Paired helical filaments in the electron microscopy of Alzheimer's disease. Nature. 197:1963;192-193.
26. Ko L., Liu W.-K, Georgieff I.S., Yen S.-H. Modulated induction of tau proteins in cultured human neuroblastoma cells. Brain Res. 707:1996;256-265.
27. Ko L., Odawara T., Yen S.-H. Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells. Brain Res. 760:1997;118-128.
28. Kosik K., Joachim C.L., Selkoe D.J. Microtubule-associated protein tau is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 83:1986;4044-4048.
29. Krantz S., Lober M., Thiele M., Teuscher E. Properties of in vitro nonenzymatically glycated plasma fibrinogens. Exp. Clin. Endocrinol. 90:1987;37-45.
30. Ksiezak-Reding H., Dickson D.W., Davies P., Yen S.-H. Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc. Natl. Acad. Sci. USA. 84:1990;3410-3414.
31. Ksiezak-Reding H., Yen S.-H. Structural stability of paired helical filaments requires microtubule-binding domains of tau: a model for self-association. Neuron. 6:1991;717-728.
32. Ksiezak-Reding H., Liu W.-K., Yen S.-H. Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res. 597:1992;209-219.
33. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
34. Ledesma M.D., Bonay P., Colaco C., Avila J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 269:1994;21614-21619.
35. Ledesma M.D., Bonay P., Avila J. Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J. Neurochem. 65:1995;1658-1664.
36. Ledesma M.D., Medina M., Avila J. The in vitro formation of recombinant tau polymers: effect of phosphorylation and glycation. Mol. Chem. Neuropathol. 27:1996;249-258.
37. Lee V.M.-Y., Balin B.J., Otvos L. Jr., Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science. 251:1991;675-678.
38. Liu W.-K., Ksiezak-Reding H., Yen S.-H. Abnormal tau proteins from Alzheimer's disease brains. Purification and amino acid analysis. J. Biol. Chem. 266:1991;21723-21727.
39. Liu W.-K., Dickson D.W., Yen S.-H. Amino acid residues 226-240 of tau, which encompass the first Lys-Ser-Pro site of tau, are partially phosphorylated in Alzheimer paired helical filament-tau. J. Neurochem. 62:1994;1055-1061.
40. Liu W.-K., Williams R.T., Hall F.L., Dickson D.W., Yen S.-H. Detection of a cdc2-related kinase associated with Alzheimer paired helical filaments. Am. J. Pathol. 146:1995;228-238.
41. Masoro E.J., Katz M.S., McMahan C.A. Evidence for the glycation hypothesis of aging from the food-restricted rodent model. J. Gerontol. 44:1989;B20-22.
42. Monnier V.M., Stevens V.J., Cerami A. Nonenzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins in experimental sugar cataracts. J. Exp. Med. 150:1979;1098-1107.
43. Monnier V.M. Nonenzymatic glycosylation, the Maillard reaction and the aging process. J. Gerontol. 45:1990;B105-B111.
44. Mori H., Kondo J., Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science. 235:1987;1641-1644.
45. Mullarkey C.J., Edelstein D., Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherosclerosis in diabetes. Biochem. Biophys. Res. Commun. 173:1990;932-939.
46. Munch G., Thome J., Foley P., Schinzel R., Riederer P. Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res. Rev. 23:1997;134-143.
47. Munch G., Mayer S., Michaelis J., Hipkiss A.R., Riederer P., Muller R., Neumann A., Schinzel R., Cunningham A.M. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochim. Biophys. Acta. 1360:1997;17-29.
48. Nacharaju P., Ko L., Yen S.-H. Characterization of in vitro glycation sites of tau. J. Neurochem. 69:1997;1709-1719.
49. Novak M. Truncated tau protein as a new marker for Alzheimer's disease. Acta Virol. 38:1994;173-189.
50. Nukina N., Ihara Y. One of the antigenic determinants of paired helical filaments is related to tau protein. J. Biochem. 99:1986;1541-1544.
51. Palinski W., Koschinsky T., Butler S.W., Miller E., Vlassara H., Cerami A., Witztum J.L. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arteriosclerosis, Thrombosis and Vascular Biol. 15:1995;571-582.
52. Perry G., Friedman R., Shaw G., Chau V. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc. Natl. Acad. Sci. USA. 84:1987;3033-3036.
53. Pongor S., Ulrich P.C., Bencsath F.A., Cerami A. Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptide with glucose. Proc. Natl. Acad. Sci. USA. 81:1984;2684-2688.
54. Reddy S., Bichler J., Wells-Knecht K.J., Thorpe S.R., Baynes J.W. N-epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry. 34:1995;10872-10878.
55. Roth M. Glycated hemoglobin, not glycosylated or glucosylated. Clin. Chem. 29:1983;1991.
56. Rubenstein R., Kascsak R.J., Merz P.A., Wisniewski H.M., Carp R.I., Iqbal K. Paired helical filaments associated with Alzheimer disease are readily soluble structures. Brain Res. 372:1986;80-88.
57. Selkoe D.J., Ihara Y., Salazar F.J. Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science. 215:1982;1243-1245.
58. Shapiro R., McManus M.J., Zalut C., Bunn H.F. Sites of nonenzymatic glycosylation of human hemoglobin A. J. Biol. Chem. 255:1980;3120-3127.
59. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.-S., Stern D., Sayre L.M., Monnier V.M., Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA. 91:1994;5710-5714.
60. Smith M.A., Sayre L.M., Monnier V.M., Perry G. Radical AGEing in Alzheimer's disease. Trends Neurosci. 18:1995;172-176.
61. Stehouwer C.D., Lambert J., Donker A.J., van Hinsbergh V.W. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc. Res. 34:1997;55-68.
62. Sullivan R. Contribution to senescence: non-enzymatic glycosylation of proteins. Arch. Physiol. Biochem. 104:1996;797-806.
63. Terry R.D., Katzman R. Senile dementia of the Alzheimer type. Ann. Neurol. 14:1964;497-506.
64. Vitek M.P., Bhattacharya K., Glendening J.M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;4766-4770.
65. Vlassara H., Brownlee M., Cerami A. Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts. J. Exp. Med. 160:1984;197-207.
66. Vlassara H., Brownlee M., Cerami A. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin. Chem. 32:1986;B37-B41.
67. Watkins N.G., Thorpe S.R., Baynes J.W. Glycation of amino groups in proteins: studies on the specificity of modification of RNase by glucose. J. Biol. Chem. 260:1985;10629-10636.
68. Wells-Knecht K.J., Brinkmann E., Wells-Knecht M.C., Litchfield J.E., Ahmed M.U., Reddy S., Zyzak D.V., Thorpe S.R., Baynes J.W. New biomarkers of Maillard reaction damage to proteins. Nephrol. Dial. Transplant. 11(5):1996;41-47. Suppl.
69. Wischik C.M., Novak M., Thogersen H.C., Edwards P.C., Runswick M.J., Jakes R., Walker J.E., Milstein C., Roth M., Klug A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 85:1988;4506-4510.
70. Wisniewski H.M., Narang H.K., Terry R.D. Neurofibrillary tangles of paired helical filaments. J. Neurol. Sci. 27:1976;173-181.
71. Wolozin B.L., Pruchnicki A., Dickson D.W., Davies P. A neuronal antigen in the brains of Alzheimer's patients. Science. 232:1986;648-650.
72. Yan S.-D., Chen X., Schmidt A.M., Brett J., Godman G., Zou Y.S., Scott C.W., Caputo C., Frappier T., Smith M.A. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA. 91:1994;7787-7791.
73. S.-H. Yen, Y. Kress, The effects of chemical reagents or proteases on the ultrastructure of paired helical filaments, in: R. Katzman (Ed.), Biological Aspects of Alzheimer's Disease, Banbury Report, Vol. 15, Cold Spring Harbor Press, Cold Spring Harbor, NY, 1983, pp. 155-165.
74. Yen S.-H., Liu W.-K., Hall F.L., Yan S.-D., Stern D., Dickson D.W. Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components. Neurobiol. Aging. 16:1995;381-387.